Evidence map›Paper›PMID 39261672›Full record

ArticleMolecular psychiatry2025

Nicotine dependence and incident psychiatric disorders: prospective evidence from US national study.

Guillaume Airagnes, Marina Sánchez-Rico, Amélia Deguilhem, Carlos Blanco, Mark Olfson, Charles Ouazana Vedrines, Cédric Lemogne, Frédéric Limosin, Nicolas Hoertel

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Guillaume AiragnesDepartment of Psychiatry and Addictology, AP-HP.Centre-Université Paris Cité, Paris, France. guillaume.airagnes@aphp.fr.ORCID 0000-0002-3494-5083
Marina Sánchez-RicoDepartment of Psychiatry and Addictology, AP-HP.Centre-Université Paris Cité, Paris, France.
Amélia DeguilhemDepartment of Psychiatry and Addictology, AP-HP.Centre-Université Paris Cité, Paris, France.ORCID 0000-0003-0619-8401
Carlos BlancoDivision of Epidemiology, Services, and Prevention Research, National Institute on Drug Abuse, Bethesda, MD, USA.ORCID 0000-0001-6187-3057
Mark OlfsonDepartment of Psychiatry, Columbia University Irving Medical Center/New York State Psychiatric Institute, New York, NY, USA.
Charles Ouazana VedrinesDepartment of Psychiatry and Addictology, AP-HP.Centre-Université Paris Cité, Paris, France.ORCID 0000-0002-3587-7182
Cédric LemogneDepartment of Psychiatry and Addictology, AP-HP.Centre-Université Paris Cité, Paris, France.ORCID 0000-0002-3487-4721
Frédéric LimosinDepartment of Psychiatry and Addictology, AP-HP.Centre-Université Paris Cité, Paris, France.ORCID 0000-0002-0976-1514
Nicolas HoertelDepartment of Psychiatry and Addictology, AP-HP.Centre-Université Paris Cité, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We examined the prospective associations between nicotine dependence and the likelihood of psychiatric and substance use disorders in the general adult population. Participants came from a nationally representative sample of US adults aged 18 years or older, who were interviewed 3 years apart in the National Epidemiologic Survey on Alcohol and Related Conditions (Wave 1, 2001-2002; Wave 2, 2004-2005). The primary analyses were limited to 32,671 respondents (13,751 male (47.9% weighted); mean age of 45 years (SD = 0.18)) who were interviewed in both waves. We used multiple regression and propensity score matching (PSM) to estimate the strength of independent associations between nicotine dependence related to the use of tobacco products at Wave 1 and incident psychiatric disorders at Wave 2. Psychiatric disorders were measured with a structured interview (Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV). All analyses adjusted for multiple potential confounders, including childhood (family history of substance use disorders, parental loss, vulnerable family environment), early-adolescence (self-esteem, social deviance, conduct disorder), late-adolescence (education, personality and psychiatric disorders), adulthood (divorce, stressful life events, social deviance, quality of life, history of alcohol or other substance use disorder), and sociodemographic factors. Multiple regression analysis and PSM converged in indicating that nicotine dependence was associated with significantly increased incidence of any psychiatric disorder (OR = 1.39(95%CI:1.20;1.60)), including substance use disorders (OR = 1.91(95%CI:1.47;2.47)), and anxiety disorders (OR = 1.31(95%CI:1.06;1.62)). Population Attributable Risk Proportions were substantial, ranging from 12.5%(95%CI:8.10;17.0) for any psychiatric disorder to 33.3%(95%CI:18.7;48.0) for any other drug use disorder. Supplementary analyses also indicated significant associations between nicotine dependence and persistence of psychiatric and substance use disorders among patients having a disorder at Wave 1. In the general adult population, nicotine dependence is associated with an increased likelihood for several psychiatric and substance use disorders. Given its high prevalence, these findings have important public health implications.

Indexed as

Mental DisordersTobacco Use DisorderAdolescentAdultFemaleHumansIncidenceMaleMiddle AgedProspective StudiesRisk FactorsSubstance-Related DisordersUnited StatesYoung Adult

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.